Skip to main content
Erschienen in: Journal of Radiation Oncology 1/2016

01.03.2016 | Original Research

Dosimetric comparison of volumetric modulated arc therapy and intensity-modulated radiation therapy for liver stereotactic ablative body radiotherapy

verfasst von: Isabelle Thibault, Matt Wronski, Renée Korol, William Chu, Joelle Helou, Darby Erler, Hans T. Chung

Erschienen in: Journal of Radiation Oncology | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Objectives

The objectives of this study were to compare the dosimetric differences between volumetric modulated arc therapy (VMAT) and intensity-modulated radiotherapy (IMRT) techniques in treatment planning for liver stereotactic ablative body radiation (SABR) and, secondly, to identify when alternative VMAT arc configurations could provide dosimetric gains.

Methods

Ten consecutive patients previously treated with IMRT to a single liver lesion were selected and planned retrospectively using VMAT while employing the same dose objectives and dose constraints. Differences in dose conformality, normal liver sparing, and organs at risk (OARs) doses were compared between the IMRT and corresponding single circumferential arc (SCA) VMAT plan for each patient. Relative dosimetric differences were quantified for each of eight alternative VMAT arc configurations.

Results

The VMAT SCA plans were associated with a 4.8 and 8.1 % improvement of the 95 % conformity index (p = 0.02) and the 50 % gradient index (p = 0.05), respectively. A trend toward significance was found for normal liver sparing and the dose to the adjacent OAR with SCA vs. IMRT. The optimal VMAT arc arrangement was a single ipsilateral 180 degree arc in patients having small (<2–3 cm) lesions away from OARs (excluding the liver), a combination of coplanar arc and non-coplanar partial arc for patients with lesions adjacent to two or more critical OARs and an SCA which was sufficient for the remaining patients.

Conclusion

VMAT planning for liver SABR provided measurably higher levels of dose conformality compared with IMRT. An ipsilateral partial arc, single circumferential arc, or circumferential arc with added non-coplanar partial arc proved to be the most promising arc configuration in the majority of patients.
Literatur
4.
Zurück zum Zitat Klein J, Korol R, Lo SS, Chu W, Lock M, Dorth JA, Ellis RJ, Mayr NA, Huang Z, Chung HT (2014) Stereotactic body radiotherapy: an effective local treatment modality for hepatocellular carcinoma. Future Oncol 10(14):2227–2241. doi:10.2217/fon.14.167 CrossRefPubMed Klein J, Korol R, Lo SS, Chu W, Lock M, Dorth JA, Ellis RJ, Mayr NA, Huang Z, Chung HT (2014) Stereotactic body radiotherapy: an effective local treatment modality for hepatocellular carcinoma. Future Oncol 10(14):2227–2241. doi:10.​2217/​fon.​14.​167 CrossRefPubMed
5.
Zurück zum Zitat Lee MT, Kim JJ, Dinniwell R, Brierley J, Lockwood G, Wong R, Cummings B, Ringash J, Tse RV, Knox JJ, Dawson LA (2009) Phase I study of individualized stereotactic body radiotherapy of liver metastases. J Clin Oncol 27(10):1585–1591. doi:10.1200/JCO.2008.20.0600 CrossRefPubMed Lee MT, Kim JJ, Dinniwell R, Brierley J, Lockwood G, Wong R, Cummings B, Ringash J, Tse RV, Knox JJ, Dawson LA (2009) Phase I study of individualized stereotactic body radiotherapy of liver metastases. J Clin Oncol 27(10):1585–1591. doi:10.​1200/​JCO.​2008.​20.​0600 CrossRefPubMed
6.
Zurück zum Zitat Chang DT, Swaminath A, Kozak M, Weintraub J, Koong AC, Kim J, Dinniwell R, Brierley J, Kavanagh BD, Dawson LA, Schefter TE (2011) Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis. Cancer 117(17):4060–4069. doi:10.1002/cncr.25997 CrossRefPubMed Chang DT, Swaminath A, Kozak M, Weintraub J, Koong AC, Kim J, Dinniwell R, Brierley J, Kavanagh BD, Dawson LA, Schefter TE (2011) Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis. Cancer 117(17):4060–4069. doi:10.​1002/​cncr.​25997 CrossRefPubMed
7.
Zurück zum Zitat Rusthoven KE, Kavanagh BD, Cardenes H, Stieber VW, Burri SH, Feigenberg SJ, Chidel MA, Pugh TJ, Franklin W, Kane M, Gaspar LE, Schefter TE (2009) Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 27(10):1572–1578. doi:10.1200/JCO.2008.19.6329 CrossRefPubMed Rusthoven KE, Kavanagh BD, Cardenes H, Stieber VW, Burri SH, Feigenberg SJ, Chidel MA, Pugh TJ, Franklin W, Kane M, Gaspar LE, Schefter TE (2009) Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 27(10):1572–1578. doi:10.​1200/​JCO.​2008.​19.​6329 CrossRefPubMed
8.
Zurück zum Zitat Tse RV, Hawkins M, Lockwood G, Kim JJ, Cummings B, Knox J, Sherman M, Dawson LA (2008) Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Clin Oncol 26(4):657–664. doi:10.1200/JCO.2007.14.3529 CrossRefPubMed Tse RV, Hawkins M, Lockwood G, Kim JJ, Cummings B, Knox J, Sherman M, Dawson LA (2008) Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Clin Oncol 26(4):657–664. doi:10.​1200/​JCO.​2007.​14.​3529 CrossRefPubMed
10.
Zurück zum Zitat Chen D, Wang R, Meng X, Liu T, Yan H, Feng R, Liu S, Jiang S, Xu X, Zhu K, Dou X (2014) A comparison of liver protection among 3-D conformal radiotherapy, intensity-modulated radiotherapy and RapidArc for hepatocellular carcinoma. Radiat Oncol 9:48. doi:10.1186/1748-717X-9-48 CrossRefPubMedPubMedCentral Chen D, Wang R, Meng X, Liu T, Yan H, Feng R, Liu S, Jiang S, Xu X, Zhu K, Dou X (2014) A comparison of liver protection among 3-D conformal radiotherapy, intensity-modulated radiotherapy and RapidArc for hepatocellular carcinoma. Radiat Oncol 9:48. doi:10.​1186/​1748-717X-9-48 CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Kuo YC, Chiu YM, Shih WP, Yu HW, Chen CW, Wong PF, Lin WC, Hwang JJ (2011) Volumetric intensity-modulated Arc (RapidArc) therapy for primary hepatocellular carcinoma: comparison with intensity-modulated radiotherapy and 3-D conformal radiotherapy. Radiat Oncol 6:76. doi:10.1186/1748-717X-6-76 CrossRefPubMedPubMedCentral Kuo YC, Chiu YM, Shih WP, Yu HW, Chen CW, Wong PF, Lin WC, Hwang JJ (2011) Volumetric intensity-modulated Arc (RapidArc) therapy for primary hepatocellular carcinoma: comparison with intensity-modulated radiotherapy and 3-D conformal radiotherapy. Radiat Oncol 6:76. doi:10.​1186/​1748-717X-6-76 CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Ogino R, Hosono M, Ishii K, Tatsumi D, Tsutsumi S, Miki Y, Masuoka Y, Shimatani Y, Miki Y (2013) A dose-volume intercomparison of volumetric-modulated arc therapy, 3D static conformal, and rotational conformal techniques for portal vein tumor thrombus in hepatocellular carcinoma. J Radiat Res 54(4):697–705. doi:10.1093/jrr/rrs139 CrossRefPubMedPubMedCentral Ogino R, Hosono M, Ishii K, Tatsumi D, Tsutsumi S, Miki Y, Masuoka Y, Shimatani Y, Miki Y (2013) A dose-volume intercomparison of volumetric-modulated arc therapy, 3D static conformal, and rotational conformal techniques for portal vein tumor thrombus in hepatocellular carcinoma. J Radiat Res 54(4):697–705. doi:10.​1093/​jrr/​rrs139 CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Tsai YC, Tsai CL, Hsu FM, Jian-Kuen W, Chien-Jang W, Cheng JC (2013) Superior liver sparing by combined coplanar/noncoplanar volumetric-modulated arc therapy for hepatocellular carcinoma: a planning and feasibility study. Med Dosim 38(4):366–371. doi:10.1016/j.meddos.2013.04.003 CrossRefPubMed Tsai YC, Tsai CL, Hsu FM, Jian-Kuen W, Chien-Jang W, Cheng JC (2013) Superior liver sparing by combined coplanar/noncoplanar volumetric-modulated arc therapy for hepatocellular carcinoma: a planning and feasibility study. Med Dosim 38(4):366–371. doi:10.​1016/​j.​meddos.​2013.​04.​003 CrossRefPubMed
15.
Zurück zum Zitat Wang PM, Hsu WC, Chung NN, Chang FL, Jang CJ, Fogliata A, Scorsetti M, Cozzi L (2014) Feasibility of stereotactic body radiation therapy with volumetric modulated arc therapy and high intensity photon beams for hepatocellular carcinoma patients. Radiat Oncol 9:18. doi:10.1186/1748-717X-9-18 CrossRefPubMedPubMedCentral Wang PM, Hsu WC, Chung NN, Chang FL, Jang CJ, Fogliata A, Scorsetti M, Cozzi L (2014) Feasibility of stereotactic body radiation therapy with volumetric modulated arc therapy and high intensity photon beams for hepatocellular carcinoma patients. Radiat Oncol 9:18. doi:10.​1186/​1748-717X-9-18 CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Helou J, Karotki A, Milot L, Chu W, Erler D, Chung HT (2015). 4DCT simulation with synchronized contrast injection in liver SBRT patients. Technol Cancer Res Treatment. doi:10.1177/1533034615572341 Helou J, Karotki A, Milot L, Chu W, Erler D, Chung HT (2015). 4DCT simulation with synchronized contrast injection in liver SBRT patients. Technol Cancer Res Treatment. doi:10.1177/1533034615572341
17.
Zurück zum Zitat Wang PM, Hsu WC, Chung NN, Chang FL, Fogliata A, Cozzi L (2013) Radiotherapy with volumetric modulated arc therapy for hepatocellular carcinoma patients ineligible for surgery or ablative treatments. Strahlenther Onkol 189(4):301–307. doi:10.1007/s00066-012-0298-6 CrossRefPubMed Wang PM, Hsu WC, Chung NN, Chang FL, Fogliata A, Cozzi L (2013) Radiotherapy with volumetric modulated arc therapy for hepatocellular carcinoma patients ineligible for surgery or ablative treatments. Strahlenther Onkol 189(4):301–307. doi:10.​1007/​s00066-012-0298-6 CrossRefPubMed
21.
22.
Zurück zum Zitat Wu QJ, Thongphiew D, Wang Z, Chankong V, Yin FF (2008) The impact of respiratory motion and treatment technique on stereotactic body radiation therapy for liver cancer. Med Phys 35(4):1440–1451CrossRefPubMed Wu QJ, Thongphiew D, Wang Z, Chankong V, Yin FF (2008) The impact of respiratory motion and treatment technique on stereotactic body radiation therapy for liver cancer. Med Phys 35(4):1440–1451CrossRefPubMed
Metadaten
Titel
Dosimetric comparison of volumetric modulated arc therapy and intensity-modulated radiation therapy for liver stereotactic ablative body radiotherapy
verfasst von
Isabelle Thibault
Matt Wronski
Renée Korol
William Chu
Joelle Helou
Darby Erler
Hans T. Chung
Publikationsdatum
01.03.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Radiation Oncology / Ausgabe 1/2016
Print ISSN: 1948-7894
Elektronische ISSN: 1948-7908
DOI
https://doi.org/10.1007/s13566-015-0220-9

Weitere Artikel der Ausgabe 1/2016

Journal of Radiation Oncology 1/2016 Zur Ausgabe

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.